Dr Paul Ryan will discuss the use of oral hypoglycaemics & their effect on patients weight. He will also discuss SGLT2s, incretin-based therapies & current diabetes guidelines on cardiovascular outcomes.

Dr Paul Ryan will discuss the main classes of hypoglycaemic agents, their efficacy & tips for prescribing different agents. He will also discuss patients with raised BMI & established cardiovascular disease & HbA1c targets.

Dr Paul Ryan will discuss the definition & diagnosis of type 2 diabetes. He will also discuss at what HbA1c does treatment need to be started, why metformin is the first-line treatment & the side effects of Metformin.

Dr Paul Ryan will discuss a number of Cochrane reviews published in the last few years that looked at the efficacy of antibiotics in common respiratory tract infections.

Dr Paul Ryan will discuss the use of delayed back-up antimicrobial prescriptions which are used where there is clinical uncertainty as to whether the condition is self-limiting or is likely to deteriorate.

Dr Paul Ryan will discuss how to approach a request for an antibiotic & how to put shared decision-making into practice regarding the prescribing of antibiotics. He will firstly discuss why antibiotics are prescribed.

Dr Paul Ryan will discuss heart failure with preserved ejection fraction (HFpEF).

Dr Paul Ryan will discuss the role of SGLT2s in chronic heart failure.

Dr Paul Ryan will discuss the role of ARNIs in patients with heart failure with reduced ejection fraction.

Dr Paul Ryan will discuss the role of diuretics in chronic heart failure with reduced ejection fraction.